Par Drugs and Chemicals Ltd
NSE:PAR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Par Drugs and Chemicals Ltd
Total Equity
Par Drugs and Chemicals Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Par Drugs and Chemicals Ltd
NSE:PAR
|
Total Equity
₹989.7m
|
CAGR 3-Years
18%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Total Equity
₹360.1B
|
CAGR 3-Years
20%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Total Equity
₹329.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
11%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Total Equity
₹778.2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
12%
|
CAGR 10-Years
11%
|
|
|
Lupin Ltd
NSE:LUPIN
|
Total Equity
₹196.3B
|
CAGR 3-Years
18%
|
CAGR 5-Years
9%
|
CAGR 10-Years
7%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Total Equity
₹84.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
Par Drugs and Chemicals Ltd
Glance View
Par Drugs & Chemicals Ltd. engages in the development and manufacture of Active Pharma Ingredients (API) for the domestic market as well as for exports to international markets. The company is headquartered in Bhavnagar, Gujarat. The company went IPO on 2019-05-16. The firm also produces a range of antacid molecules. The Company’s products include magnesium hydroxide, magnesium trisilicate, magnesium carbonate, light magnesium oxide, magnesium oxide heavy, magnesium oxide USP, dried aluminum hydroxide gel, magaldrate, magnesium aluminum silicate hydrated, alma gate, hydrotalcite, aluminum hydroxide magnesium carbonate co-dried gel, aluminum-magnesium silicate BP, sodium aluminum silicate, precipitated silica, magnesium silicate, amorphous, colloidal silicon dioxide and sucralfate USP. The firm owns and operates its manufacturing facilities at Bhavnagar in Gujarat. The company has over four manufacturing blocks at Bhavnagar, which are for different products having a capacity of approximately 9,700 metric tons per annum.
See Also
What is Par Drugs and Chemicals Ltd's Total Equity?
Total Equity
989.7m
INR
Based on the financial report for Mar 31, 2025, Par Drugs and Chemicals Ltd's Total Equity amounts to 989.7m INR.
What is Par Drugs and Chemicals Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
20%
Over the last year, the Total Equity growth was 16%. The average annual Total Equity growth rates for Par Drugs and Chemicals Ltd have been 18% over the past three years , 20% over the past five years .
